Do you routinely offer AR-v7 testing to determine whether to treat with chemotherapy versus enzalutamide or abiraterone in metastatic castration resistant prostate cancer?  


Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice